| Bioactivity | Eflucimibe (F 12511) is a new acyl-coenzyme A cholesterol O-acyltransferase (ACAT) inhibitor. Eflucimibe can be used in the research of atherosclerosis[1]. |
| Name | Eflucimibe |
| CAS | 202340-45-2 |
| Formula | C29H43NO2S |
| Molar Mass | 469.72 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nathalie Mesplet, et al. Analysis of eflucimibe and related impurities by highly sensitive liquid chromatography-electrospray-tandem mass spectrometry. The Journal of Separation Science. 2003. |
Eflucimibe
CAS: 202340-45-2 F: C29H43NO2S W: 469.72
Eflucimibe (F 12511) is a new acyl-coenzyme A cholesterol O-acyltransferase (ACAT) inhibitor. Eflucimibe can be used in
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.